Chuna Manual Therapy for Cervicogenic Dizziness
Chuna Manual Therapy for Cervicogenic Dizziness
This is a prospective, pragmatic, assessor-blind, randomized controlled trial to explore the
 effectiveness of an adjuvant Chuna manual therapy (CMT) for cervicogenic dizziness of
 Dizziness Handicap Inventory (DHI) ≥ 16 at baseline. Participants will be randomized and
 allocated to either CMT combined with usual care (UC) group or UC group with 1:1 ratio. They
 will receive 12 sessions of CMT or UC treatment for 6 weeks. UC consists of physical therapy
 and patients education.
Inclusion Criteria:

 -  male or female aged between 20 and 70

 -  neck pain and/or stiffness with dizziness, which is related to movement or positioning
 of cervical spine

 -  recurring symptom of dizziness over 1 month or more

 -  Dizziness Handicap Inventory ≥ 16 at baseline

 -  Informed consent

 Exclusion Criteria:

 -  dizziness induced by vestibular disorders (e.g., benign paroxysmal positional vertigo,
 peripheral vestibulopathy, Meniere disease, vestibular neuronitis)

 -  dizziness induced by central nervous system (CNS) disorders (e.g., cerebellar
 ataxia,cerebellum infarction/hemorrhage, demyelination, vertebrobasilar insufficiency,
 seizure, increased intracranial pressure, Parkinson's disease, migraines)

 -  dizziness induced by cardiovascular disorders (e.g., arrhythmia, heart valvular
 disease, anemia, orthostatic hypotension, coronary artery disease)

 -  dizziness induced by active or uncontrolled disease (e.g., uncontrolled diabetes
 mellitus, hypertension, respiratory or endocrinological disorders)

 -  dizziness induced by side effects of medications

 -  severe chronic or terminal diseases (malignant cancer, tuberculosis, etc.)

 -  chronic psychiatric diseases under treatment (epilepsy, depression, panic disorder,
 etc.)

 -  conditions where CMT are forbidden (spinal tumor, acute fracture, infectious
 spondylopathy, congenital malformations of spine, operation history of spine within 3
 months, progressive neurological damage, severe neurological symptoms, spinal fixation
 devices, syringomyelia, hydrocephaly)

 -  Treatment history within 1 week for cervicogenic dizziness (NSAIDs, steroid, herbal
 drug, acupuncture, manual therapy)

 -  Women of (suspected) pregnancy or breast-feeding

 -  Suspicion of alcohol and/or drug abuse

 -  Participation in another clinical study within 1 month

 -  Difficulty in communicating with the investigators

 -  Other reasons for ineligibility of participation